Joseph Klein III - Nov 15, 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
Joseph Klein, III
Stock symbol
IONS
Transactions as of
Nov 15, 2023
Transactions value $
-$100,000
Form type
4
Date filed
11/17/2023, 04:58 PM
Previous filing
Sep 28, 2023
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Sale -$100K -2K -10.9% $50.00 16.3K Nov 15, 2023 Direct F1
holding IONS Common Stock 100 Nov 15, 2023 by Son F2
holding IONS Common Stock 6K Nov 15, 2023 by Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 17, 2022
F2 The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.